Document Detail


Enhancement of myocardial vulnerability by atrial fibrillation.
MedLine Citation:
PMID:  14704594     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Certain groups are known to have an increased risk for sudden cardiac death. Epidemiologic studies have suggested that patients with atrial fibrillation may be at higher risk. The authors hypothesize that atrial fibrillation may increase myocardial vulnerability. To test this hypothesis, 37 dogs were studied using programmed electrical stimulation techniques to determine myocardial vulnerability as assessed by the ability to provoke ventricular tachycardia. Prior to atrial fibrillation, programmed electrical stimulation did not induce ventricular tachycardia. Aconitine was then topically applied to the right atrial appendage with care taken not to make contact with the ventricle. Application of aconitine caused atrial fibrillation with an increase in ventricular rate, but did not affect arterial blood pressure. Ventricular tachycardia was induced by programmed electrical stimulation studies in 25 of 26 dogs in atrial fibrillation. The enhanced vulnerability was noted following atrial fibrillation, not after aconitine application to the great veins, which did not cause atrial fibrillation. To further exclude the possibility that aconitine application may cause changes in ventricular threshold, atrial fibrillation was induced by pacing techniques in five dogs. Prior to atrial fibrillation induction, programmed electrical stimulation did not induce ventricular tachycardia. Following atrial fibrillation, ventricular tachycardia could be repeatedly induced. Mean heart rate following atrial fibrillation increased, while pacing animals at this increment in rate did not change the noninducibility of dogs in sinus rhythm. Six patients with a history of atrial fibrillation and ventricular tachycardia were studied to determine if AF lowered myocardial threshold to VT induction. Ventricular tachycardia could only be induced by PES techniques in four of five patients when the patients' rhythm was AF (P < 0.05). This study suggests that atrial fibrillation lowers myocardial threshold for ventricular tachycardia induction and thus enhances myocardial vulnerability. The association of AF with a higher incidence of sudden death may be due to an enhanced electrical instability.
Authors:
John C Somberg; Vilma Torres; Gad Keren; Brenda Butler; David Tepper; Herman Kleinbaum; Janos Molnar
Related Documents :
1274864 - Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation t...
8572814 - Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibril...
6838264 - Should ventricular fibrillation be induced prior to the infusion of cardioplegic solution?
4015264 - Efficacy of disopyramide in comparison with verapamil and propranolol in the prevention...
484504 - Bilateral cardiac myxomas and peripheral myxomas in a patient with recent myocardial in...
23244364 - Assessing reverse remodeling in heart failure patients treated with cardiac resynchroni...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  11     ISSN:  1075-2765     ISO Abbreviation:  Am J Ther     Publication Date:    2004 Jan-Feb
Date Detail:
Created Date:  2004-01-05     Completed Date:  2004-05-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  33-43     Citation Subset:  IM    
Affiliation:
Department of Medicine & Pharmacology, Rush University and American Institute of Therapeutics, 21 N. Skokie Valley Highway, Suite G-3, Lake Bluff, IL 60044, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aconitine
Animals
Atrial Fibrillation / complications*
Death, Sudden / prevention & control
Disease Models, Animal
Disease Susceptibility
Dogs
Electric Stimulation
Female
Heart Rate
Heart Ventricles
Hemodynamics
Humans
Male
Middle Aged
Tachycardia, Ventricular / etiology*,  physiopathology
Chemical
Reg. No./Substance:
302-27-2/Aconitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone...
Next Document:  Renin-angiotensin system as a therapeutic target in managing atherosclerosis.